Immunogenicity and Safety of Post-Exposure Rabies Vaccination in Children with Primary Immunodeficiency Disorders

Patients with primary immunodeficiency disorders(PIDs) are at risk when expose to rabies since they may have poor antibody responses to rabies vaccination. Our study aimed to evaluate the rabies neutralizing antibody responses (Nab) and safety of rabies vaccine for post-exposure treatment in PID patients after 6 months of vaccination.